Clinical studies and applications of cyclic nucleotides.
D000342:Affective Symptoms / Q000378:metabolism; D000818:Animals; D001249:Asthma / Q000378:metabolism; D002110:Caffeine / Q000494:pharmacology; D002116:Calcitonin / Q000494:pharmacology; D002118:Calcium / Q000378:metabolism; D002395:Catecholamines / Q000494:pharmacology; D002940:Circadian Rhythm; D000242:Cyclic AMP / Q000097:blood / Q000378:metabolism* / Q000652:urine; D006152:Cyclic GMP / Q000097:blood / Q000378:metabolism* / Q000652:urine; D003876:Dermatitis, Atopic / Q000378:metabolism; D003919:Diabetes Insipidus / Q000378:metabolism; D005934:Glucagon / Q000494:pharmacology; D013006:Growth Hormone / Q000494:pharmacology; D006801:Humans; D006934:Hypercalcemia / Q000378:metabolism; D006961:Hyperparathyroidism / Q000378:metabolism; D006996:Hypocalcemia / Q000378:metabolism; D007011:Hypoparathyroidism / Q000378:metabolism; D007328:Insulin / Q000494:pharmacology; D009928:Organ Specificity; D010281:Parathyroid Hormone / Q000494:pharmacology; D011565:Psoriasis / Q000378:metabolism; D014667:Vasopressins / Q000494:pharmacology
D002395:Catecholamines; D007328:Insulin; D010281:Parathyroid Hormone; D014667:Vasopressins; D002110:Caffeine; D013006:Growth Hormone; D002116:Calcitonin; D005934:Glucagon; D000242:Cyclic AMP; D006152:Cyclic GMP; D002118:Calcium